Monogram Orthopaedics
MGRM
MGRM was delisted on the 6th of October, 2025.
26 hedge funds and large institutions have $1.13M invested in Monogram Orthopaedics in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
16% more capital invested
Capital invested by funds: $974K → $1.13M (+$158K)
0.38% more ownership
Funds ownership: 1.28% → 1.66% (+0.38%)
10% less funds holding
Funds holding: 29 → 26 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$348K |
| 2 |
BlackRock
New York
|
+$44.3K |
| 3 |
HF
HRT Financial
New York
|
+$37.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$30K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$8.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWM
Prosperity Wealth Management
San Ramon,
California
|
-$83.9K |
| 2 |
Millennium Management
New York
|
-$35.8K |
| 3 |
VF
Virtu Financial
New York
|
-$32K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$29.4K |
| 5 |
JP Morgan Chase
New York
|
-$16.4K |
MGRM Hedge Fund Activity: Q2 2024 in Review
26 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Monogram Orthopaedics (MGRM) for Q2 2024, worth a combined $1.13M — up 16% from $974K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MGRM and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, opening a new position worth an estimated $348K. The largest seller was Prosperity Wealth Management, exiting entirely with an estimated $83.9K sold.
- 26 institutional investors held Monogram Orthopaedics (MGRM) as of Q2 2024, down from 29 in Q1 2024.
- Funds reported $1.13M of Monogram Orthopaedics stock for Q2 2024, up 16% quarter-over-quarter.
- 2 funds opened new Monogram Orthopaedics positions in Q2 2024 and 5 closed out, a net change of -3 holders.
- The largest Monogram Orthopaedics buyer in Q2 2024 was Vanguard Group, an estimated $348K added.
- The largest Monogram Orthopaedics seller in Q2 2024 was Prosperity Wealth Management, an estimated $83.9K sold.
Based on aggregated 13F filings for Q2 2024.